Biotech Wants Answers On Ex-GC's Role In Securities Scheme
Cancer treatment developer Neogenix Oncology Inc. wants answers from its former chief legal officer about the securities sale program that bankrupted the company, moving in New York federal court on Wednesday...To view the full article, register now.
Already a subscriber? Click here to view full article